| 0.6505 0.007 (1.01%) | 01-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.79 | 1-year : | 0.86 |
| Resists | First : | 0.67 | Second : | 0.74 |
| Pivot price | 0.66  |
|||
| Supports | First : | 0.57 | Second : | 0.48 |
| MAs | MA(5) : | 0.64  |
MA(20) : | 0.65 |
| MA(100) : | 0.79 |
MA(250) : | 0.98 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 35.5 |
D(3) : | 39.3 |
| RSI | RSI(14): 45.9 |
|||
| 52-week | High : | 1.65 | Low : | 0.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ICCM ] has closed above bottom band by 28.5%. Bollinger Bands are 46.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.66 - 0.67 | 0.67 - 0.67 |
| Low: | 0.64 - 0.64 | 0.64 - 0.64 |
| Close: | 0.64 - 0.65 | 0.65 - 0.66 |
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Thu, 15 Jan 2026
When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? - Yahoo Finance
Mon, 12 Jan 2026
A frozen alternative to breast surgery gains U.S. authorization - Stock Titan
Thu, 08 Jan 2026
IceCure Medical (ICCM) adopts new Articles after special meeting vote - Stock Titan
Thu, 08 Jan 2026
When Can We Expect A Profit From IceCure Medical Ltd (NASDAQ:ICCM)? - simplywall.st
Wed, 26 Nov 2025
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 69 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 40.4 (%) |
| Held by Institutions | 0.4 (%) |
| Shares Short | 966 (K) |
| Shares Short P.Month | 1,160 (K) |
| EPS | -0.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.14 |
| Profit Margin | 0 % |
| Operating Margin | -451.3 % |
| Return on Assets (ttm) | -63.5 % |
| Return on Equity (ttm) | -158 % |
| Qtrly Rev. Growth | 28.3 % |
| Gross Profit (p.s.) | 0.01 |
| Sales Per Share | 0.04 |
| EBITDA (p.s.) | -0.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -14 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -2.61 |
| PEG Ratio | 0 |
| Price to Book value | 4.64 |
| Price to Sales | 15.05 |
| Price to Cash Flow | -3.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|